Matches in SemOpenAlex for { <https://semopenalex.org/work/W2008687669> ?p ?o ?g. }
- W2008687669 endingPage "858.e4" @default.
- W2008687669 startingPage "847" @default.
- W2008687669 abstract "Thiopurine therapy for inflammatory bowel disease (IBD) has been associated with increased risk for lymphoma. We estimated the relative risk of lymphoma in patients with IBD exposed to thiopurines and compared relative risk values derived from population-based studies with those from referral center-based studies. We investigated whether active use increased risk compared with past use, and whether sex, age, or duration of use affects risk of lymphoma.We searched MEDLINE, EMBASE, and Cochrane databases, as well as conference abstracts and international publications, for the terms 6-MP and lymphoma, 6-mercaptopurine and lymphoma, thiopurines and lymphoma, azathioprine and cancer and IBD, azathioprine and malignancy and IBD, azathioprine and lymphoma, and lymphoproliferative and thiopurines. Pooled standardized incidence ratios (SIRs) and 95% confidence intervals (CIs) were estimated. The deviance statistic from Poisson models was used to calculate heterogeneity.Eighteen studies (among 4383 citations) met our inclusion criteria. Overall, the SIR for lymphoma was 4.92 (95% CI, 3.10-7.78), ranging from 2.80 (95% CI, 1.82-4.32) in 8 population studies to 9.24 (95% CI, 4.69-18.2) in 10 referral studies. Population studies demonstrated an increased risk among current users (SIR = 5.71; 95% CI, 3.72-10.1) but not former users (SIR = 1.42; 95% CI, 0.86-2.34). Level of risk became significant after 1 year of exposure. Men have a greater risk than women (relative risk = 1.98; P < .05); both sexes were at increased risk for lymphoma (SIR for men = 4.50; 95% CI = 3.71-5.40 and SIR for women = 2.29; 95% CI = 1.69-3.05). Patients younger than 30 years had the highest relative risk (SIR = 6.99; 95% CI, 2.99-16.4); younger men had the highest risk. The absolute risk was highest in patients older than 50 years (1:354 cases per patient-year, with a relative risk of 4.78).Compared with studies from referral centers, population-based studies of IBD patients show a lower but significantly increased risk of lymphoma among patients taking thiopurines. The increased risk does not appear to persist after discontinuation of therapy. Patients over 50 have the highest absolute risk of lymphoma per year on thiopurines, while men under 35 may also be a high risk group. More study is needed to precisely understand groups highest at risk. The risks of lymphoma and potential benefits of therapy should be considered for all patients with IBD." @default.
- W2008687669 created "2016-06-24" @default.
- W2008687669 creator A5009437472 @default.
- W2008687669 creator A5011368312 @default.
- W2008687669 creator A5029517825 @default.
- W2008687669 creator A5031453430 @default.
- W2008687669 creator A5035191721 @default.
- W2008687669 creator A5041280886 @default.
- W2008687669 creator A5041936168 @default.
- W2008687669 creator A5042884495 @default.
- W2008687669 creator A5044524314 @default.
- W2008687669 creator A5046814722 @default.
- W2008687669 creator A5056592637 @default.
- W2008687669 creator A5066241193 @default.
- W2008687669 creator A5066754667 @default.
- W2008687669 creator A5074679114 @default.
- W2008687669 creator A5086343499 @default.
- W2008687669 creator A5087405062 @default.
- W2008687669 date "2015-05-01" @default.
- W2008687669 modified "2023-10-18" @default.
- W2008687669 title "Risk of Lymphoma in Patients With Inflammatory Bowel Disease Treated With Azathioprine and 6-Mercaptopurine: A Meta-analysis" @default.
- W2008687669 cites W1925602349 @default.
- W2008687669 cites W1955108199 @default.
- W2008687669 cites W1957194282 @default.
- W2008687669 cites W1970234962 @default.
- W2008687669 cites W1974943298 @default.
- W2008687669 cites W1977445011 @default.
- W2008687669 cites W1980442626 @default.
- W2008687669 cites W1995372822 @default.
- W2008687669 cites W1996715439 @default.
- W2008687669 cites W2003063732 @default.
- W2008687669 cites W2005097349 @default.
- W2008687669 cites W2016321388 @default.
- W2008687669 cites W2016704705 @default.
- W2008687669 cites W2019886362 @default.
- W2008687669 cites W2024704046 @default.
- W2008687669 cites W2045123507 @default.
- W2008687669 cites W2048717004 @default.
- W2008687669 cites W2059114415 @default.
- W2008687669 cites W2061928454 @default.
- W2008687669 cites W2070246874 @default.
- W2008687669 cites W2072163745 @default.
- W2008687669 cites W2074229951 @default.
- W2008687669 cites W2075154100 @default.
- W2008687669 cites W2088322611 @default.
- W2008687669 cites W2091648050 @default.
- W2008687669 cites W2093690138 @default.
- W2008687669 cites W2100942700 @default.
- W2008687669 cites W2125435699 @default.
- W2008687669 cites W2134590709 @default.
- W2008687669 cites W2142612410 @default.
- W2008687669 cites W2144494294 @default.
- W2008687669 cites W2148298419 @default.
- W2008687669 cites W2158129844 @default.
- W2008687669 cites W2160917743 @default.
- W2008687669 cites W2165765440 @default.
- W2008687669 cites W248910915 @default.
- W2008687669 cites W4252431323 @default.
- W2008687669 cites W4376595875 @default.
- W2008687669 doi "https://doi.org/10.1016/j.cgh.2014.05.015" @default.
- W2008687669 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24879926" @default.
- W2008687669 hasPublicationYear "2015" @default.
- W2008687669 type Work @default.
- W2008687669 sameAs 2008687669 @default.
- W2008687669 citedByCount "309" @default.
- W2008687669 countsByYear W20086876692014 @default.
- W2008687669 countsByYear W20086876692015 @default.
- W2008687669 countsByYear W20086876692016 @default.
- W2008687669 countsByYear W20086876692017 @default.
- W2008687669 countsByYear W20086876692018 @default.
- W2008687669 countsByYear W20086876692019 @default.
- W2008687669 countsByYear W20086876692020 @default.
- W2008687669 countsByYear W20086876692021 @default.
- W2008687669 countsByYear W20086876692022 @default.
- W2008687669 countsByYear W20086876692023 @default.
- W2008687669 crossrefType "journal-article" @default.
- W2008687669 hasAuthorship W2008687669A5009437472 @default.
- W2008687669 hasAuthorship W2008687669A5011368312 @default.
- W2008687669 hasAuthorship W2008687669A5029517825 @default.
- W2008687669 hasAuthorship W2008687669A5031453430 @default.
- W2008687669 hasAuthorship W2008687669A5035191721 @default.
- W2008687669 hasAuthorship W2008687669A5041280886 @default.
- W2008687669 hasAuthorship W2008687669A5041936168 @default.
- W2008687669 hasAuthorship W2008687669A5042884495 @default.
- W2008687669 hasAuthorship W2008687669A5044524314 @default.
- W2008687669 hasAuthorship W2008687669A5046814722 @default.
- W2008687669 hasAuthorship W2008687669A5056592637 @default.
- W2008687669 hasAuthorship W2008687669A5066241193 @default.
- W2008687669 hasAuthorship W2008687669A5066754667 @default.
- W2008687669 hasAuthorship W2008687669A5074679114 @default.
- W2008687669 hasAuthorship W2008687669A5086343499 @default.
- W2008687669 hasAuthorship W2008687669A5087405062 @default.
- W2008687669 hasConcept C126322002 @default.
- W2008687669 hasConcept C2776760755 @default.
- W2008687669 hasConcept C2777173762 @default.
- W2008687669 hasConcept C2778260677 @default.
- W2008687669 hasConcept C2779134260 @default.
- W2008687669 hasConcept C2779338263 @default.